Citations 1
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
Yacoub, Abdulraheem , Mascarenhas, John , Prchal, Josef T. , Berenzon, Dmitry, Baer, Maria R. , Ritchie, Ellen K. , Silver, Richard T. , Winton, Elliott F., Finazzi, Maria Chiara , Rambaldi, Alessandro , Leibowitz, D , Rondelli, Damiano , Arcasoy, Murat O. , Catchatourian, Rosalind, Vadakara, Joseph , Kremyanskaya, Marina , Sandy, Lonette, Tripodi, Joseph , Najfeld, Vesna , Farnoud, Noushin , Papaemmanuil, Elli , Salama, Mohamed E. , Singer-Weinberg, Rona, Rampal, Raajit K. , Goldberg, Judith D. , Barbui, Tiziano , Dueck, Amylou C. , Salama, Mohamed , Dueck, A. C. , Tripodi, Joseph , Mascarenhas, John , Goldberg, Judith D , Rambaldi, Alessandro , Najfeld, Vesna , Kosiorek, Heidi , Kessler, Craig M. , Vannucchi, Alessandro M. , Rosti, Vittorio , Hexner, Elizabeth O. , Mesa, Ruben A. , Hoffman, Ronald , Prchal, Josef T.
Blood | September 13, 2019 | Volume: 134 | Issue: 18 | Pages: 1498-1509
Yacoub et al report excellent responses to pegylated interferon alfa-2a in patients with hydroxyurea-resistant/intolerant polycythemia vera or essential thrombocythemia.